← Leaderboards
John L. Nitiss
University Of Illinois At Chicago
$5,416,388
Attributed
$5,416,388
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $595.3K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,416,388 · 6
By mechanism
R01$5,016,423 · 2
R03$399,965 · 3
P01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Etoposide”
- Gregory H Reaman · National Childhood Cancer Foundation$18,332,016
- Charles A Coltman · Southwest Oncology Group$18,209,974
- Sharon B. Murphy · Northwestern University$7,718,936
- David Macpherson · Carnegie Institution Of Washington, D.C.$7,200,975
- Neil Osheroff · Vanderbilt University$6,364,254
- Stephen J Forma · City Of Hope/Beckman Research Institute$4,494,326
Research focus
EtoposideDna TopoisomerasesDna DamageYeastsMutantSaccharomyces CerevisiaeBiochemicalTopoisomerase IiProteinsTopoisomeraseMutationComplexMediatingAntineoplastic AgentsPlayPharmaceutical PreparationsDna RepairAffectLeadEnzyme InhibitorsDrug ResistanceDrug SensitivityFungal GeneticsEnzymes
Grant awards (27)
Biochemical determinants of genome instability induced by eukaryotic topoisomerase II$80,165
R03 · FY2025 · CA · contact PI
Genome Instability induced in cancer cells carrying mutations in Type II topoisomerases$79,950
R03 · FY2023 · CA · contact PI
Genome Instability induced in cancer cells carrying mutations in Type II topoisomerases$79,950
R03 · FY2022 · CA · contact PI
Novel approaches for studying topoisomerase 2 targeting anti-cancer drugs$79,950
R03 · FY2018 · CA · contact PI
Novel approaches for studying topoisomerase 2 targeting anti-cancer drugs$79,950
R03 · FY2017 · CA · contact PI
Anti-topoisomerase drug action in yeast$274,696
R01 · FY2014 · CA · contact PI
Anti-topoisomerase drug action in yeast$266,200
R01 · FY2013 · CA · contact PI
Anti-topoisomerase drug action in yeast$282,872
R01 · FY2012 · CA · contact PI
Anti-topoisomerase drug action in yeast$158,838
R01 · FY2011 · CA · contact PI
Anti-topoisomerase drug action in yeast$124,288
R01 · FY2011 · CA · contact PI
Anti-topoisomerase drug action in yeast$325,112
R01 · FY2010 · CA · contact PI
DNA Repair and Antitopoisomerase Drug Effects$264,187
R01 · FY2010 · CA · contact PI
DNA Repair and Antitopoisomerase Drug Effects$5,953
R01 · FY2010 · CA · contact PI
DNA Repair and Antitopoisomerase Drug Effects$270,140
R01 · FY2009 · CA · contact PI
DNA Repair and Antitopoisomerase Drug Effects$270,140
R01 · FY2008 · CA · contact PI
DNA Repair and Antitopoisomerase Drug Effects$265,718
R01 · FY2007 · CA · contact PI
DNA Repair and Antitopoisomerase Drug Effects$269,514
R01 · FY2006 · CA · contact PI
ANTI TOPOISOMERASE DRUG ACTION IN YEAST$261,000
R01 · FY2004 · CA
ANTI TOPOISOMERASE DRUG ACTION IN YEAST$261,000
R01 · FY2003 · CA
DNA REPAIR AND ANTITOPOISOMERASE DRUG EFFECTS$244,412
R01 · FY2003 · CA
ANTI TOPOISOMERASE DRUG ACTION IN YEAST$261,000
R01 · FY2002 · CA
DNA REPAIR AND ANTITOPOISOMERASE DRUG EFFECTS$237,333
R01 · FY2002 · CA
GRP78/BIP PATHWAYS IN ANTITUMOR DRUG RESPONSE$0
P01 · FY2002 · CA
ANTI TOPOISOMERASE DRUG ACTION IN YEAST$261,000
R01 · FY2001 · CA
DNA REPAIR AND ANTITOPOISOMERASE DRUG EFFECTS$230,460
R01 · FY2001 · CA
ANTI TOPOISOMERASE DRUG ACTION IN YEAST$258,773
R01 · FY2000 · CA
DNA REPAIR AND ANTITOPOISOMERASE DRUG EFFECTS$223,787
R01 · FY2000 · CA